4//SEC Filing
D'Alvise Janelle 4
Accession 0001171843-22-004514
CIK 0001444192other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 4:33 PM ET
Size
5.6 KB
Accession
0001171843-22-004514
Insider Transaction Report
Form 4
D'Alvise Janelle
DirectorPRESIDENT & CEO
Transactions
- Award
Stock Options (Right to Buy)
2022-06-22+560,000→ 560,000 totalExercise: $0.89Exp: 2032-06-22→ Class A Common Shares (560,000 underlying)
Footnotes (2)
- [F1]Based on conversion of exercise price of C$1.15 into U.S. dollars based on an exchange rate of C$1.00 = US$0.7727 on the date of grant.
- [F2]Stock options granted on 06/22/2022 under Acasti Pharma Inc.'s Stock Option Plan and become exercisable evenly and on a quarterly basis over 36 months.
Documents
Issuer
Acasti Pharma Inc.
CIK 0001444192
Entity typeother
Related Parties
1- filerCIK 0001807412
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 4:33 PM ET
- Size
- 5.6 KB